Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
INmune Bio Inc. Common stock
IPO Date: February 4, 2019
Sector: Healthcare
Industry: Biotechnology
Market Cap: $56.39M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.36 | 3.88%
Avg Daily Range (30 D): $0.39 | 7.51%
Avg Daily Range (90 D): $0.32 | 5.07%
Institutional Daily Volume
Avg Daily Volume: .24M
Avg Daily Volume (30 D): 4.37M
Avg Daily Volume (90 D): 1.66M
Trade Size
Avg Trade Size (Sh.): 115
Avg Trade Size (Sh.) (30 D): 128
Avg Trade Size (Sh.) (90 D): 121
Institutional Trades
Total Inst.Trades: 26
Avg Inst. Trade: $1.45M
Avg Inst. Trade (30 D): $2M
Avg Inst. Trade (90 D): $1.26M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.74M
Avg Closing Trade (30 D): $2M
Avg Closing Trade (90 D): $1.26M
Avg Closing Volume: 185.19K
   
News
Jun 26, 2025 @ 8:00 PM
INmune Bio Inc. to Announce Top Line Results from ...
Source: Inmune Bio Inc.
Jul 19, 2024 @ 9:53 PM
Inmune Bio re-elects directors, ratifies auditor -...
Source: Natashya Angelica
Jul 12, 2024 @ 11:37 AM
Zura Bio initiates exchange offer for warrants By ...
Source: Ismeta Mujdragic
May 30, 2024 @ 12:00 PM
INmune Bio Inc. to Join Russell 3000® Index
Source: INmune Bio, Inc.
May 9, 2024 @ 8:05 PM
INmune Bio Inc. Announces First Quarter 2024 Resul...
Source: INmune Bio, Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.43 $-.4 $-2.11
Diluted EPS $-.43 $-.4 $-2.11
Revenue $ .05M $ M $ .01M
Gross Profit $ $ $
Net Income / Loss $ -9.74M $ -9.22M $ -42.08M
Operating Income / Loss $ -9.91M $ -9.47M $ -42.64M
Cost of Revenue $ $ $
Net Cash Flow $ .04M $ -.46M $ -.22M
PE Ratio